ACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read moreThe U.S. Department of Health and Human Services Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT (ASTP/ONC) convened its annual meeting Feb 11-12. Thomas Keane, MD, MBA, an interventional radiologist who heads the agency, gave the keynote address. Assistant Secretary Keane highlighted progress toward ASTP/ONC’s three policy priorities: data liquidity, healthcare affordability and access, and technological advancement — including efforts to address regulatory and economic issues that prevent the adoption of AI in clinical practice. ASTP/ONC recognized prior ACR® efforts to advance image exchange and interoperability during the meeting.
ACR joined government leaders and industry partners to ask questions related to several HHS comment opportunities, including a request for information (RFI) that seeks input on clinical AI regulation, reimbursement, and research and development to advance AI use in patient care; a notice of proposed rulemaking (NPRM), which will update ASTP/ONC’s health IT certification program and information blocking rules; and an RFI seeking input on interoperability standards and certification for diagnostic image exchange. ACR is preparing comments for each of these opportunities.
If you have questions about the ASTP/ONC annual meeting or the comment opportunities, contact Lindsay Robbins, ACR Regulatory Policy Specialist.
ACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read moreAC Update Regards Lung Diseases
Stay current with ACR Appropriateness Criteria updates featuring new and revised guidance for lung disease imaging.
Read moreFY27 NIH Appropriations
ACR urges Congress to finalize FY27 NIH funding, protecting biomedical research, medical innovation and advances in patient care.
Read more